Not to be inj intravascularly or intradermally. Thrombocytopenia or clotting problems. Monitor temp for 48 hr after vaccination in childn w/ history of febrile convulsions unrelated to a previous vaccination. Syncope; phenylketonuria. Carefully consider giving further doses of pertussis-containing vaccine in: Fever ≥40°C; collapse or shock-like state w/ hypotonic-hyporesponsive episode (drop in energy) w/in 48 hr of vaccination; persistent, inconsolable crying lasting ≥3 hr occurring w/in 48 hr of vaccination; convulsions w/ or w/o fever occurring w/in 3 days of vaccination. Childn w/ history of Guillain-Barré syndrome or brachial neuritis following receipt of prior vaccine containing tetanus toxoid; current, or history of, allergic reaction following Tetraxim inj; oedematous reactions of lower limbs after inj of
H. influenzae type b-containing vaccine. Diphtheria-tetanus-pertussis-poliomyelitis vaccine & the
H. influenzae type b conjugate vaccine should be administered in 2 separate inj sites & on 2 different days. Immunosuppressed patients. Assess history of afebrile convulsions not related to a previous vaccine inj. Intended for paed use only.
Sign Out
